Loading clinical trials...
Loading clinical trials...
The aim of this study was to evaluate the 7 mm long implants NobelSpeedy Shorty and Brånemark System Mk III Shorty: by determining the marginal bone remodeling, implant survival rate, soft tissue health and maintenance.
The primary endpoint was the change in marginal bone levels (in mm) from the time of implant insertion to follow-up visits (3, 6, 12, 36 and 60 months). Further endpoints were: * cumulative survival rates of the implants * soft tissue parameters (papilla index, bleeding on probing) * plaque formation
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Start Date
October 1, 2007
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
April 22, 2016
38
ACTUAL participants
Shorty implants
DEVICE
Lead Sponsor
Nobel Biocare
NCT07315607
NCT06666595
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions